LESLIE POPE: Open Payments
NPI 1285193714 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 17 payments from 10 companies in 2025. Trend: 2023 $171 · 2024 $187 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 4 | $71 |
| Astellas Pharma US Inc | 3 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| Ethicon US, LLC | 1 | $23 |
| Laborie Medical Technologies Corp. | 1 | $22 |
| REVANCE THERAPEUTICS, INC. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
Products named: Veozah, MYFEMBREE, INJECTAFER, LO LOESTRIN FE, ABRYSVO, Harmonic, Eclipse, DAXXIFY.
Industry payments across CA — which companies pay providers there.
